Stay updated on Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T06:11:01.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new version of a clinical trial study on pancreatic cancer, including the addition of collaborators and a revision number, while significant details about the trial's objectives and treatment methods have been removed.
    Difference
    57%
    Check dated 2025-04-16T20:24:58.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 19, 2025.
    Difference
    0.4%
    Check dated 2025-04-09T13:19:53.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-02T00:07:38.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The webpage has been updated with new results reporting dates and additional details regarding the assessment of treatment outcomes, including the overall response rate and T-cell infiltration metrics. Notably, the previous objective response rate based on RECIST 1.1 has been removed.
    Difference
    10%
    Check dated 2025-02-24T22:52:21.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T16:03:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page.